How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?

On June 22, AbbVie (ABBV +0.04%) announced that it would acquire Apogee Therapeutics (APGE 0.06%) for $10.9 billion in cash.